As the studies come in examining the effectiveness and side effects of their product, there will be further changes in laws and recommendations. Both the causes of migraines and the potential results of CBD stay unclear. A lot of studies specific to the elements of marijuana, like CBD, are necessary.
There is no scientific evidence or research on medical marijuana as an effective treatment for migraine and anxiety—in large part because it has not been formally studied. However, it may still be a viable topical option for some patients with joint and muscle pain associated with migraines. “If you have a lot of neck pain or soreness, it is perfectly reasonable to use CBD. It may even prevent nausea and vomiting,” Dr. Silberstein says.
In this article, we have found the top best cbd oil for migraine options that are sure to get you results. Each offers incredible return policies so that you are able to choose the right dosage for all of your needs!
The CBD Oil For Migraines & Headaches (June. 2021)
Migraines can make it difficult to participate in different activities. The constant thumping in your head can make it difficult to concentrate and can even cause nausea, chronic pain, and other symptoms that are difficult to manage with the standard treatment of migraines. Medical marijuana has a long history of use as a powerful painkiller, but CBD oil seems to offer more extended benefits and acting as an endocannabinoid system reuptake inhibitor. The compound produces many of the positive health effects associated with marijuana, but without the narcotic side effects. Hence, that’s why we researched the best CBD oil for migraines.
People who suffer from migraines, it’s simple to get excited hearing regarding new effective treatment that has been good and effective for others, however, you should thoroughly research at new rising trends to check if the proof is really there, or if it’s simply more hype. Unfortunately, this could be tough to do when it comes to using CBD because of a lack of adequate research, and contraband laws in some locations.
CBD oil has received plenty of praise recently from individuals touting its ability to alleviate and even stops the pain caused by migraine headaches. Simply take a look at the popular online message board Reddit to check that there are lots of people that swear by its all-natural healing power. Some customers even state to have experienced relief from their migraines by using topical CBD products by applying them to temples, jaw, or neck muscles.
That’s where cannabinoid oil comes into play because it may reduce the strength of the cells located in the brain that cause migraine pain. Taking CBD oil can help sufferers eliminate the pain they feel for months on end.
As of 2015, Fife et al (2015) summarized their conclusions regarding utility of Cannabis in neurological disorders. There was evidence for effectiveness in spasticity, central pain in MS. Nabiximols was thought to be "probably effective" in reducing bladder spasms (this drug is also used to treat nausea, see below). In movement disorders such as tremor, Huntington disease, and dopamine related dyskinesias, it was thought either ineffective or unknown. For Epilepsy, as of 2015, it was unknown.
An individual diagnosed with one or more debilitating conditions is eligible to apply for a medical cannabis registry identification card. The qualifying patient must obtain a written certification from a physician specifying their debilitating condition, unless they are a veteran receiving health services at a VA facility. Veterans must submit one year of medical records from the VA facility where they receive services. Effective January 1, 2015, the Act was amended to include eligibility for children under age 18 and to add seizure disorders to the list of debilitating conditions. On June 30, 2016, the Act was amended (Public Act 099-0519) to add Post-Traumatic Stress Disorder (PTSD) as a debilitating condition and to allow persons diagnosed with a terminal illness to apply for a medical cannabis registry identification card. The Act is effective until Jan, 1, 2020.
There are presently (in 2015) no studies of cannabis for treatment of dizziness, and dizziness appears to be more of a side effect than a therapeutic target (Grotenhermen et al, 2012). Smith (2006) suggested that there are cannabinoid receptors in the central vestibular system. More studies are needed. We have had heard from our patients that they have sometimes had a good response to a non-mind altering component of cannabis (CBD). In theory, this might be related to the anti-seizure effects of some components of cannabis. At this date (early 2018), these are just anecdotes. Products that we have been told were helpful are "Charlotte’s Web", "Watermelon Pucks", and "Anandahemp 200". The first is CBD oil, and can easily be ordered from the internet. The second contains some THC, and is not as readily available. As noted above, THC is approved by the FDA for treatment of nausea and vomiting associated with chemotherapy, and thus it is not surprising that "Watermelon Pucks" might be helpful in some people with dizziness. To be very clear, I am not advocating for these products, but I am simply transmitting what patients are telling me.
Prescription forms of cannabinoids include:
THC (brand name Dronabinol) has been extensively studied with placebo controlled trials for nausea. A similar drug called Nabilone is also available. Both of these have been approved by the FDA for treatment of nausea and vomiting associated with chemotherapy. Another substance called "Nabiximol" is not currently FDA approved for nausea, but it is licensed in other countries and appears to be similar.
McGeeney (2012) suggests that anecdotal evidence suggests that they "are used" by patients for migraine, including as an abortive, and for cluster headache. Baron (2015) also suggests that there is some evidence for a good effect in migraine. As there is some evidence for an effect in chronic pain, one would anticipate a positive effect also in chronic migraine. Thus evidence is currently extremely weak. According to Baron (2018), a chemical called anandamide inhibits dilation of blood vessels, modulates CGRP, and cortical spreading depression. CB1 also inhibits pain responses. We consider this also anecdotal.
As of 2019, cannabis is scheduled to be available for recreational use by early 2020. Presently, In Illinois, the Illinois Compassionate Use of Medical Cannabis Pilot Program requires physicians to certify the diagnosis of a debilitating condition or terminal illness for a qualifying patient seeking to apply for a medical cannabis registry identification card. Whether or not a physician chooses to provide a written physician certification is up to the health care practitioner. More information is here: https://www.dph.illinois.gov/topics-services/prevention-wellness/medical-cannabis/physician-information According to Fife et al (2015), the system used in Illinois is the usual one used to handle the odd situation where the Federal government states that licensed physicians cannot legally prescribe herbal marijuana (although they may prescribe nabilone or dronabinol). Physicians can document that the patient has a medical condition that justifies the use of marijuana under that state’s law. Patients then may proceed to acquire the marijuana, under the particulars of the laws of their state. Nevertheless, certain institutions, including the Department of Veteran affairs, may have policies banning physicians from discussing medical marijuana with their patients. Note that THC can be detected in the urine as long as 12 days after a single "dose". This means that in Illinois, should one be involved in an auto accident, it is theoretically possible to be cited for DUI, 12 days after ingesting a small amount of medical marijuana.